(FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (Q6)Jun 30, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | 74.17%6.43B | ---- | -82.73%3.69B | ---- | -18.91%21.4B | ---- | 22.01%26.39B | ---- | 15.97%21.63B | ---- |
Profit adjustment | ||||||||||
Interest (income) - adjustment | 26.26%-324.54M | ---- | 16.70%-440.1M | ---- | 18.36%-528.36M | ---- | 10.23%-647.2M | ---- | -213.95%-720.92M | ---- |
Dividend (income)- adjustment | 65.32%-378K | ---- | 96.42%-1.09M | ---- | -420.46%-30.47M | ---- | 15.39%-5.85M | ---- | -7.22%-6.92M | ---- |
Attributable subsidiary (profit) loss | -52.66%-1.53B | ---- | 51.54%-1B | ---- | 29.36%-2.07B | ---- | -54.87%-2.93B | ---- | -22.25%-1.89B | ---- |
Impairment and provisions: | 16.54%4.65B | ---- | -0.20%3.99B | ---- | 165.67%4B | ---- | 53.71%1.5B | ---- | 195.13%978.58M | --0 |
-Impairment of property, plant and equipment (reversal) | -7.44%3.3B | ---- | 0.97%3.56B | ---- | 162.31%3.53B | ---- | 61.79%1.35B | ---- | 378.55%831.73M | ---- |
-Other impairments and provisions | 218.06%1.35B | ---- | -9.06%424.11M | ---- | 194.19%466.37M | ---- | 7.95%158.53M | ---- | -6.92%146.85M | ---- |
Revaluation surplus: | 86.49%-193.84M | ---- | 50.68%-1.43B | ---- | -28.94%-2.91B | ---- | 24.30%-2.26B | ---- | 20.04%-2.98B | --0 |
-Fair value of investment properties (increase) | 98.40%-23.35M | ---- | 47.88%-1.46B | ---- | -21.08%-2.79B | ---- | 5.41%-2.31B | ---- | 25.78%-2.44B | ---- |
-Other fair value changes | -919.82%-170.48M | ---- | 117.93%20.8M | ---- | -329.10%-115.97M | ---- | 109.34%50.62M | ---- | -22.65%-541.68M | ---- |
Asset sale loss (gain): | -513.05%-1.58B | ---- | 1,586.05%382.23M | ---- | 84.39%-25.72M | ---- | -3.83%-164.8M | ---- | -124.03%-158.72M | --0 |
-Loss (gain) from sale of subsidiary company | -404.74%-1.15B | ---- | 2,035.51%377.44M | ---- | 88.21%-19.5M | ---- | -257.18%-165.43M | ---- | 36.10%-46.32M | ---- |
-Loss (gain) on sale of property, machinery and equipment | -9,056.61%-428.57M | ---- | 176.93%4.79M | ---- | -1,076.45%-6.22M | ---- | -97.11%637K | ---- | 1,241.19%22.01M | ---- |
-Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---134.41M | ---- |
Depreciation and amortization: | -2.59%638.1M | ---- | -24.25%655.03M | ---- | -4.03%864.76M | ---- | 31.79%901.06M | ---- | 53.79%683.73M | --0 |
-Depreciation | -3.99%519.21M | ---- | -5.56%540.79M | ---- | -2.14%572.64M | ---- | 9.00%585.14M | ---- | 34.90%536.82M | ---- |
-Other depreciation and amortization | 4.07%118.89M | ---- | -60.89%114.24M | ---- | -7.53%292.12M | ---- | 115.04%315.92M | ---- | 214.90%146.91M | ---- |
Financial expense | -11.91%2.6B | ---- | 112.94%2.96B | ---- | -14.84%1.39B | ---- | 2.90%1.63B | ---- | 196.05%1.58B | ---- |
Exchange Loss (gain) | -89.03%61.89M | ---- | 469.08%563.99M | ---- | 63.33%-152.81M | ---- | -259.73%-416.7M | ---- | -39.92%260.88M | ---- |
Special items | -48.96%63.96M | ---- | 1,035.06%125.32M | ---- | -94.39%11.04M | ---- | 379.96%196.93M | ---- | -50.65%41.03M | ---- |
Operating profit before the change of operating capital | 14.07%10.82B | ---- | -56.76%9.49B | ---- | -9.32%21.94B | ---- | 24.63%24.19B | ---- | 30.35%19.41B | --0 |
Change of operating capital | ||||||||||
Developing property (increase)decrease | 29.41%59.17B | ---- | 80.12%45.72B | ---- | 201.62%25.38B | ---- | 61.96%-24.98B | ---- | -0.37%-65.67B | ---- |
Accounts receivable (increase)decrease | -85.37%709.13M | ---- | 5,081.79%4.85B | ---- | -107.77%-97.29M | ---- | 123.44%1.25B | ---- | -35.96%-5.34B | ---- |
Accounts payable increase (decrease) | 58.12%-5.81B | ---- | -95.83%-13.87B | ---- | -133.38%-7.08B | ---- | -26.20%21.22B | ---- | 41.93%28.76B | ---- |
prepayments (increase)decrease | -66.06%402.97M | ---- | -86.88%1.19B | ---- | 174.44%9.05B | ---- | -193.28%-12.16B | ---- | 442.76%13.03B | ---- |
Special items for working capital changes | -77.97%-52.86B | ---- | -2,139.36%-29.7B | ---- | ---1.33B | ---- | ---- | ---- | ---- | ---- |
Cash from business operations | -29.65%12.43B | -46.92%9.31B | -44.47%17.67B | 434.48%17.54B | 279.55%31.82B | 183.20%3.28B | -83.99%8.38B | -277.91%-3.94B | 458.40%52.37B | 88.20%-1.04B |
China income tax paid | 49.60%-2.05B | 57.96%-1.19B | 60.72%-4.07B | 63.49%-2.84B | -23.09%-10.37B | -34.92%-7.78B | 4.89%-8.43B | 3.41%-5.76B | -55.36%-8.86B | -58.50%-5.97B |
Interest paid - operating | 28.56%-4.38B | 29.72%-2.3B | -4.77%-6.13B | 2.47%-3.27B | 11.15%-5.85B | -8.21%-3.35B | -12.42%-6.58B | -13.56%-3.09B | -74.54%-5.86B | -98.84%-2.72B |
Net cash from operations | -19.66%6B | -49.09%5.82B | -52.14%7.46B | 245.74%11.43B | 335.36%15.6B | 38.73%-7.84B | -117.60%-6.63B | -31.49%-12.8B | 11,632.67%37.66B | 30.35%-9.74B |
Cash flow from investment activities | ||||||||||
Interest received - investment | 6.12%319.88M | -18.76%137.31M | -27.44%301.43M | -35.28%169.02M | -27.41%415.43M | -6.57%261.17M | 13.65%572.29M | 42.80%279.53M | 119.30%503.56M | 53.97%195.75M |
Dividend received - investment | 18.20%1.32B | -36.85%296.84M | 27.37%1.12B | 308.17%470.05M | -72.11%877.95M | -91.67%115.16M | 117.56%3.15B | 4,219.09%1.38B | 950.05%1.45B | 16.11%32M |
Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | --140.63M | 737.65%93.72M | ---- | ---14.7M | --140.24M | ---- |
Sale of fixed assets | 134.28%871.51M | -85.37%4.46M | 288.86%372M | -49.08%30.49M | 52.45%95.66M | 2.33%59.88M | 11.00%62.75M | 70.63%58.51M | -10.52%56.53M | 366.63%34.29M |
Purchase of fixed assets | 75.88%-278.54M | 80.03%-218M | 21.31%-1.15B | -156.67%-1.09B | -21.61%-1.47B | 64.19%-425.27M | -113.21%-1.21B | -831.11%-1.19B | -13.16%-565.94M | -128.09%-127.55M |
Selling intangible assets | ---- | --714.59M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Purchase of intangible assets | 99.49%-2.66M | ---- | -537.87%-520.66M | ---- | 88.10%-81.63M | ---- | -5,730.00%-685.67M | ---- | 49.38%-11.76M | ---- |
Sale of subsidiaries | 400.13%1.38B | -57.40%145.43M | 150.72%275.83M | 187.92%341.43M | -191.66%-543.79M | -268.73%-388.36M | -70.69%593.28M | --230.17M | 515.63%2.02B | ---- |
Recovery of cash from investments | -61.39%9.15B | -50.45%341.19M | 1,806.64%23.7B | -24.38%688.61M | 19.80%1.24B | 237.20%910.59M | 5.56%1.04B | 147.27%270.04M | 198.18%982.85M | 546.32%109.21M |
Cash on investment | 63.94%-9.06B | 68.05%-5.82B | -11.47%-25.13B | 61.70%-18.23B | 25.03%-22.55B | -1,985.01%-47.59B | -99.00%-30.07B | 75.52%-2.28B | 22.06%-15.11B | -28.02%-9.32B |
Other items in the investment business | -104.99%-41.09M | -66.92%5.1B | 459.38%823.26M | -59.24%15.4B | -98.37%147.17M | 5,267.92%37.8B | 388.19%9.01B | 527.35%704.1M | 231.29%1.85B | 1,282.90%112.23M |
Net cash from investment operations | 1,774.27%3.66B | 131.36%694.15M | 98.99%-218.47M | 75.85%-2.21B | -23.83%-21.72B | -1,535.98%-9.17B | -101.84%-17.54B | 93.75%-560.3M | 58.71%-8.69B | -24.16%-8.97B |
Net cash before financing | 33.23%9.65B | -29.33%6.51B | 218.34%7.25B | 154.19%9.22B | 74.66%-6.12B | -27.30%-17.01B | -183.43%-24.17B | 28.55%-13.36B | 239.76%28.97B | 11.78%-18.7B |
Cash flow from financing activities | ||||||||||
New borrowing | -24.42%20.11B | -18.25%12.83B | -58.37%26.61B | -60.62%15.69B | -15.05%63.92B | 11.64%39.85B | 51.10%75.24B | -15.64%35.69B | -16.95%49.79B | 40.68%42.31B |
Refund | 32.74%-36.64B | 35.24%-19.43B | 15.23%-54.47B | -1.99%-30B | -11.48%-64.26B | -22.93%-29.41B | -11.27%-57.64B | -13.00%-23.93B | -97.20%-51.8B | -135.09%-21.18B |
Issuing shares | ---- | ---- | --3.01B | --1.28B | ---- | ---- | --2.39B | --2.39B | ---- | ---- |
Dividends paid - financing | -155.67%-1.6B | 68.94%-130.55M | 86.37%-626.41M | -184.03%-420.32M | -9.87%-4.6B | 79.70%-147.99M | -32.16%-4.18B | 75.48%-729.16M | -61.72%-3.16B | -92.30%-2.97B |
Absorb investment income | ---- | ---- | ---- | ---- | -26.05%10.46B | ---- | 140.70%14.14B | -21.18%4.2B | -35.45%5.87B | 607.02%5.33B |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---100.98M | ---- | ---- | ---- | -5.90%-158.8M | ---- | 46.09%-149.96M | -275.05%-149.96M |
Other items of the financing business | 87.24%-751.99M | 60.26%-1.43B | 49.35%-5.89B | -497.01%-3.61B | -89.48%-11.63B | 121.87%908.23M | 44.16%-6.14B | 27.17%-4.15B | -1,815.98%-10.99B | -299.93%-5.7B |
Net cash from financing operations | 40.01%-18.88B | 51.99%-8.21B | -414.53%-31.47B | -252.71%-17.09B | -125.86%-6.12B | -16.93%11.19B | 326.40%23.65B | -23.59%13.47B | -125.32%-10.45B | -27.59%17.63B |
Effect of rate | -73.01%14.45M | -32.14%-15.05M | 143.99%53.53M | 65.53%-11.39M | 41.47%-121.7M | -247.32%-33.04M | -392.44%-207.91M | 53.59%-9.51M | -128.22%-42.22M | -116.77%-20.5M |
Net Cash | 61.92%-9.22B | 78.51%-1.69B | -97.91%-24.22B | -35.35%-7.87B | -2,263.46%-12.24B | -5,311.77%-5.82B | -102.80%-517.86M | 110.45%111.62M | -9.75%18.52B | -133.88%-1.07B |
Begining period cash | -51.86%22.44B | -51.86%22.44B | -20.96%46.6B | -20.96%46.6B | -1.22%58.97B | -1.22%58.97B | 44.83%59.69B | 44.83%59.69B | 100.63%41.21B | 100.63%41.21B |
Cash at the end | -41.05%13.23B | -46.46%20.73B | -51.86%22.44B | -27.10%38.72B | -20.96%46.6B | -11.17%53.12B | -1.22%58.97B | 49.02%59.79B | 44.83%59.69B | 68.47%40.13B |
Cash balance analysis | ||||||||||
Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
Auditor | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data